We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 11
Most popular |Most recent

Patent and Pharma Update - May 2016

United Kingdom - May 12 2016 Regeneron's patents concerning transgenic mice models have been held invalid for insufficiency as they did not enable a skilled person to perform the...

Jonathan Turnbull, Krishna Kakkaiyadi.

Patent and Pharma Update - December 2015

United Kingdom, European Union - December 29 2015 The Court of Appeal reversed the judge's finding that two of Leo Pharma's patents for a psoriasis ointment were invalid for obviousness. The key...

Christopher Sharp, Clare Blendis.

Patent and pharma update June 2015

United Kingdom, European Union - June 15 2015 The Court of Justice of the European Union has rejected Spain's second round of challenges to the Regulations establishing a unitary patent system via...

Christopher Sharp, Anna Vandervliet.

A golden ticket for licensees? Patentee ordered to disclose licence documents before infringement proceedings begin

United Kingdom - May 5 2015 In an 'unprecedented' application, the Patents Court has ordered pre-action disclosure of a patentee's existing licence agreements, so that the...

Sophie Rich.

Novartis feels the 'squeeze': broad claim construction leads to invalidity of patent for EXELON Alzheimer's patch

United Kingdom, European Union - April 30 2015 Arnold J in the Patents Court has found that Novartis' patent, covering its EXELON rivastigmine transdermal patch to treat Alzheimer's disease, is...

Sebastian Moore.